Houston, November 25, 2025
Coya Therapeutics, a Houston-based biotech firm, is set to participate in two significant conferences focusing on neurodegenerative diseases. These events, including the 8th Annual Evercore Healthcare Conference and the CTAD Conference, underscore Coya’s commitment to innovation in treatments for conditions like Alzheimer’s disease. By enhancing regulatory T cell (Treg) function through biologics, Coya aims to make strides against systemic inflammation impacting neurodegenerative disorders. The conferences will provide a platform for collaboration and investment opportunities within the biotech landscape.
Houston Biotech Firm Coya Therapeutics to Shine at Key Conferences
Coya Therapeutics showcases innovation and commitment in the fight against neurodegenerative diseases.
Houston, Texas – Coya Therapeutics, Inc. (NASDAQ: COYA), a pioneering clinical-stage biotechnology company, has announced its participation in two prominent industry conferences that are critical to advancing the understanding of neurodegenerative disorders. These events highlight the resilience and innovation of Houston’s business landscape, particularly in the biotechnology sector, which thrives on collaboration and scientific advancement.
Coya’s focus on enhancing regulatory T cell (Treg) function through biologics addresses systemic inflammation—a significant contributor to various neurodegenerative conditions such as Alzheimer’s disease. This strategic emphasis resonates with Houston’s entrepreneurial spirit, showcasing the potential of local companies to tackle complex challenges through research and innovation.
Upcoming Conferences
Coya Therapeutics will take part in:
- 8th Annual Evercore Healthcare Conference on December 2, 2025, featuring a fireside chat by Dr. Arun Swaminathan, Ph.D., Chief Executive Officer.
- 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference, also on December 2, 2025, featuring a roundtable discussion on combination therapies in Alzheimer’s disease.
These conferences present an invaluable opportunity for Coya Therapeutics to engage with investors and industry peers, emphasizing the company’s commitment to drive innovation in the treatment of neurodegenerative diseases.
Commitment to Innovation and Collaboration
Coya Therapeutics’ participation in these key events reflects its proactive approach to fostering partnerships and collaboration within the biotechnology ecosystem. The presence of its management team for one-on-one meetings at the Evercore Conference demonstrates the company’s willingness to connect with potential investors and share its vision for future advancements in neuroregulatory therapies.
Focus on Combination Therapies
The roundtable discussion at the CTAD Conference focuses on the critical topic of combination therapies for Alzheimer’s disease. As this disease affects millions, exploring collaborative solutions to treatment options can potentially lead to breakthroughs that will enhance patient care and quality of life. The emphasis on teamwork among scientists, clinicians, and policymakers underscores the necessity of collective efforts in confronting this global health challenge.
About Coya Therapeutics, Inc.
Founded and headquartered in Houston, TX, Coya Therapeutics, Inc. is dedicated to developing proprietary treatments focused on enhancing Treg function to mitigate the effects of neurodegenerative disorders. By targeting underlying systemic inflammation through various therapeutic modalities, Coya aims to restore balance to the immune system, showcasing the transformative potential of innovative, locally-developed biotechnologies.
Supporting Local Entrepreneurship
Coya Therapeutics stands as a testament to the strong entrepreneurial culture in Houston, where limited regulatory frameworks and supportive business environments can drive innovation. As Coya prepares for these conferences, it symbolizes the collective ambition of Houston’s biotech sector to not only contribute to local economic growth but also to make a global impact in healthcare.
Conclusion
Coya Therapeutics’ engagement at the upcoming conferences highlights the dynamic nature of Houston’s biotech scene, emphasizing the importance of collaboration, research, and innovation. As local companies continue to push boundaries in scientific exploration and development, the Houston community is encouraged to support these efforts, championing advancements that promise improved health outcomes for individuals affected by neurodegenerative diseases.
FAQ
What are the upcoming conferences Coya Therapeutics is participating in?
Coya Therapeutics is participating in the 8th Annual Evercore Healthcare Conference and the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference, both on December 2, 2025.
Who will represent Coya Therapeutics at these conferences?
Dr. Arun Swaminathan, Ph.D., Chief Executive Officer, will participate in a fireside chat at the Evercore Conference.
What is the focus of the CTAD Conference roundtable discussion?
The roundtable discussion at the CTAD Conference is titled “Charting the Path Forward for Combination Therapy in Alzheimer’s Disease: Challenges, Considerations, and Collaborative Solutions.”
How can I access the webcast of the Evercore Conference presentation?
The live and archived webcast of the Evercore Conference presentation will be accessible on Coya Therapeutics’ website under the Investor Relations section – Events and Presentations.
What is the mission of Coya Therapeutics?
Coya Therapeutics is focused on developing biologics that enhance regulatory T cell (Treg) function in patients with neurodegenerative disorders.
Key Features
| Feature | Details |
|---|---|
| Upcoming Conferences | 8th Annual Evercore Healthcare Conference and 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference on December 2, 2025. |
| CEO Participation | Dr. Arun Swaminathan, Ph.D., CEO, will participate in a fireside chat at the Evercore Conference. |
| CTAD Conference Focus | Roundtable discussion on combination therapies in Alzheimer’s disease. |
| Webcast Access | Live and archived webcast of the Evercore Conference presentation available on Coya’s website. |
| Company Mission | Developing biologics to enhance Treg function in neurodegenerative disorders. |
Deeper Dive: News & Info About This Topic
HERE Resources
Author: STAFF HERE HOUSTON TX WRITER
The HOUSTON STAFF WRITER represents the experienced team at HEREHouston.com, your go-to source for actionable local news and information in Houston, Harris County, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as Houston Livestock Show and Rodeo, Art Car Parade, and Chevron Houston Marathon. Our coverage extends to key organizations like the Greater Houston Partnership and Houston Area Urban League, plus leading businesses in energy and healthcare that power the local economy such as ExxonMobil, Schlumberger, and Houston Methodist. As part of the broader HERE network, including HEREAustinTX.com, HERECollegeStation.com, HEREDallas.com, and HERESanAntonio.com, we provide comprehensive, credible insights into Texas's dynamic landscape.
